ストックスクリーナーアプリを入手
2.517
5.31%
0.127
アフターアワーズ：
2.54
0.023
+0.91%
前日終値:
$2.39
開ける：
$2.42
24時間の取引高:
52,800
Relative Volume:
0.37
時価総額：
$77.11M
収益：
$6.21M
当期純損益:
$-19.92M
株価収益率:
-2.3971
EPS:
-1.05
ネットキャッシュフロー:
$-16.76M
1週間 パフォーマンス:
+7.11%
1か月 パフォーマンス:
+2.32%
6か月 パフォーマンス:
-14.39%
1年 パフォーマンス:
+6.65%
1日の値動き範囲:
$2.39
$2.54
1週間の範囲:
$2.2709
$2.54
52週間の値動き範囲:
$1.99
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
NSPR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.517 | 71.99M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2016-01-07 | 開始されました | Rodman & Renshaw | Buy |
| 2015-03-13 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2013-11-26 | 開始されました | Oppenheimer | Outperform |
InspireMD Inc. (NSPR) 最新ニュース
What drives InspireMD Inc. stock priceUnprecedented profit potential - Autocar Professional
InspireMD Inc. Stock Analysis and ForecastFree Risk Assessment Services - jammulinksnews.com
What analysts say about InspireMD Inc. stockFree Investment Portfolio Suggestions - Autocar Professional
Is InspireMD Inc. a good long term investmentBreakthrough investment results - Autocar Professional
Brown Advisory Inc. Takes $27,000 Position in InspireMD, Inc. (NYSE:NSPR) - Defense World
InspireMD Shares Rise on U.S. Rollout of CGuard Prime Carotid Stent - MSN
InspireMD Launches CGuard Prime Carotid Stent System in the U.S. - MSN
What makes InspireMD Inc. stock price move sharplyInvestor Favorite Picks - Newser
How InspireMD Inc. stock performs during market volatilityChart Breakout Alert - Newser
Why InspireMD Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser
InspireMD launches CGuard Prime carotid stent in US after FDA approval By Investing.com - Investing.com South Africa
InspireMD Launches Carotid Stent System for the Preventing Strokes - Diagnostic and Interventional Cardiology
InspireMD stock rises after US commercial launch of carotid stent system - Investing.com Nigeria
InspireMD stock rises after US commercial launch of carotid stent system By Investing.com - Investing.com South Africa
InspireMD Launches CGuard Prime Stent in U.S. Market - TipRanks
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke - The Manila Times
InspireMD launches CGuard Prime carotid stent in US after FDA approval - Investing.com
NSPR launches CGuard Prime in U.S.; 8-K filed with Exhibit 99.1 | NSPR SEC FilingForm 8-K - Stock Titan
InspireMD, Inc.(NasdaqCM: NSPR) added to Russell 3000E Index - MarketScreener
Why Did InspireMD Plunge 10.71% Despite FDA Approval? - AInvest
InspireMD Gains FDA Approval for CGuard Stent System - TipRanks
InspireMD’s embolic prevention system gains CE Mark approval - Yahoo Finance
InspireMD receives CE mark approval for CGuard Prime stent system By Investing.com - Investing.com South Africa
InspireMD Gains CE Mark for Stroke Device CGuard Prime - MarketScreener
InspireMD Gains CE Mark Approval for CGuard® Prime - TipRanks
InspireMD announces CE Mark approval for CGuard Prime EPS - TipRanks
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke - The Manila Times
InspireMD, Inc. Secures CE Mark Approval for CGuard® Prime EPS Carotid Stent System - Nasdaq
InspireMD Announces CE Mark Approval for CGuard® Prime - GlobeNewswire
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke - GlobeNewswire Inc.
Millennium Management LLC Has $867,000 Position in InspireMD, Inc. (NYSE:NSPR) - Defense World
Medical device company appoints CFO - The Business Journals
InspireMD appoints Michael Lawless CFO - MSN
Northern Trust Corp Acquires 24,452 Shares of InspireMD, Inc. (NYSE:NSPR) - Defense World
InspireMD names Michael Lawless as new CFO By Investing.com - Investing.com South Africa
InspireMD Appoints Michael Lawless as CFO - marketscreener.com
InspireMD (NSPR) Announces New CFO Appointment | NSPR Stock News - GuruFocus
InspireMD Inc. (NSPR) 財務データ
収益
当期純利益
現金流量
EPS
1.15%
0.17%
大文字化:
|
ボリューム (24 時間):